Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 364 | Longs Won 166/363 45% | Profit Factor 0.94 |
| Profitability | Shorts Won 1/1 100% | Standard Deviation $3,775.12 |
| Average Win $1,058.79 | Best Trade (Aug 18) $22,565.22 | Sharpe Ratio -101.73 |
| Average Loss -$957.3 | Worst Trade (Mar 11) -$53,822.63 | Z-Score -4.68 (100%) |
| Commissions $0 | Avg. Trade Length 1m 2w 6d | Expectancy -$32.34 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 92 | 83 | 74 | 65 | 55 | 46 | 37 | 28 | 18 | 9 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
INO Inovio Pharmaceuticals, Inc. | 87,356.27 | $78,620.64 | $88,229.83 | - | $9,609.19 | 12.22% | -2.885% |